Earth Science Tech Inc. (OTC: ETST) reported financial results for the fiscal year ended March 31, 2026, demonstrating growth across key metrics as the company advances its vertically integrated healthcare platform. The diversified holding company, which operates in healthcare, pharmaceuticals, telemedicine, real estate, and consumer businesses, posted revenue of $35.7 million, an 8% increase year-over-year. Gross profit rose 5% to $25.5 million, while net income grew 11% to $3.6 million. Total assets surged 27% to $9 million, reflecting the company's expansion and strategic investments.
CEO Giorgio R. Saumat attributed the results to ETST's ongoing efforts to fully integrate the patient experience from telemedicine to pharmacy to fulfillment. This seamless integration is central to the company's value proposition, achieved through synergies among its specialized subsidiaries. The company's core strategy involves building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. These healthcare operations are supported by investments in real estate, asset management, and a consumer products business.
The fiscal 2026 performance underscores the effectiveness of ETST's diversified holdings model, which aims to create a comprehensive ecosystem for patient care. By connecting telemedicine consultations with pharmacy services and direct fulfillment, the company seeks to streamline healthcare delivery and improve patient outcomes. The growth in revenue and net income indicates growing adoption of its integrated approach, while the increase in total assets suggests continued investment in infrastructure and capabilities.
For more details on the financial results, visit https://nnw.fm/u6mhk. To learn more about Earth Science Tech and its operations, visit www.EarthScienceTech.com. For the latest news and updates relating to ETST, the company's newsroom is available at https://nnw.fm/ETST.
